Exciting News! Our Gainesville Office has moved to Bristow9450 Innovation Drive, Manassas, VA 20110.  Same great providers and care team, same exceptional care, new, larger space to better serve our patients.

Journal of Clinical Oncology - ASCO Pub - Abstract - Pancreatic Cancer and other GI Tumors harboring a KRAS (G12C) Mutation. Alex Spira, MD, PhD, FACP

Virginia Cancer Specialists Practice Blog

January 20, 2022
Virginia Cancer Specialists » VCS Practice News » Physicians » VCS Practice News » Alex Spira » Journal of Clinical Oncology – ASCO Pub – Abstract – Pancreatic Cancer and other GI Tumors harboring a KRAS (G12C) Mutation. Alex Spira, MD, PhD, FACP

KRYSTAL-1: Updated activity and safety of adagrasib (MRTX849) in patients (Pts) with unresectable or metastatic pancreatic cancer (PDAC) and other gastrointestinal (GI) tumors harboring a KRASG12C mutation.

, , , , , , , , , , , , , Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ; US Oncology Research/Virginia Cancer Specialists, Fairfax, VA; Memorial Sloan Kettering Cancer Center, New York, NY; Southern California Permenente Medical Group, Los Angeles, CA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Sarah Cannon Research Institute, Nashville, TN; Texas Oncology, Dallas, TX; Yale University School of Medicine, New Haven, CT; Mirati Therapeutics, Inc., San Diego, CA; Janssen Research and Development, LLC, San Diego, CA; Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI

Learn More here: https://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.519?utm_medium=cpc&utm_campaign=J_Clin_Oncol_TrendMD_0&utm_source=TrendMD#.Yei3b8vXpqs.twitter

Award Winning Physicians

Our Physicians work for you, ensuring the highest standard of care.

Learn More